Predictive Technology Group Inc. has acquired Regenerative Medical Technologies Inc., adding to the company's work in degenerative disc disease.
The deal covers the purchase of a stem cell product design, intellectual property, data and medical records, along with a clinical trial methodology for degenerative disc disease.
According to Salt Lake City-based Predictive Technology, lower back pain affects 266 million people globally, with degenerative disc disease being the most common cause.
Predictive Technology and its units focus on diagnostics for endometriosis, scoliosis, degenerative disc disease and other conditions.
Financial details for the acquisition were not disclosed.